29.02.2012 • NewsHCS GroupDow Haltermannsales and profits

Haltermann Reports Postive First 6 Months

Six months after Haltermann, previously a subsidiary of Dow, became an independent company, Haltermann's CEO, Dr. Uwe Nickel has expressed satisfaction with how business is developing. Dr Nickel is optimistic about the future. Since the company was spun-off in July 2011, Haltermann, which specializes in high-purity refinery chemicals, increased its revenue by 20% over the previous year. In a press release, the company said it has been able to pass on the high price increase of raw materials. Nickel is cautious about 2012 expectations.

"We will only have clarity about the market development after the first three to five months of 2012," he said.

 

 

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.